By labeling solubilized cell membrane expressing Cav2.2 with 125I-labeled ω-conotoxin GVIA, and exposing this to LEMS patient serum, antibodies against Cav2.2 can bind the receptor-conotoxin complex. Here, CACNA1B is linked to Lambert-Eaton myasthenic syndrome.